Dalvance
Sanofi patent case win holds off generic rivals for key cancer drug
Boosts hope of increasing future sales
Peter Kelly named managing director of Accord Healthcare UK
He was previously commercial director at Actavis UK
Lilly wins on appeal in Alimta vitamin regimen dispute
UK Supreme Court rules in its favour over Actavis
Teva sells UK and Ireland assets to Intas Pharma for £603m
Generics portfolio and manufacturing facility gain set to double Indian firm’s UK sales
UK court backs Actavis in dispute over Lilly’s Alimta
Actavis’ generic version ruled not to infringe Lilly’s intellectual property
UK government fines GSK over ‘pay-for-delay’ deals
Merck KGaA and Actavis also fined for their involvement
Horizon launches $3bn hostile bid for Depomed
Horizon wants to add Depomed’s pain therapies and CNS drugs to its products
Teva planning fresh offer for Mylan, say sources
Israeli firm has already made multiple informal bids
Receptos rejected AZ takeover bid, say sources
Sources also claim the Delaware-based firm is being chased by Gilead Sciences and Teva
Shire rumoured to be pursuing Actelion
Allegedly made a £12.4bn takeover bid for the Swiss biopharma
Pfizer ‘bids €1.5bn’ for CAR-T specialist Cellectis
French immuno-oncology biotech reported to be next on pharma giant's hit list
